Malaria vaccine (FMP-012) (Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command)

N/A

Report date: 2022/09/02 20:00:31

Base Information

Drug NameMalaria vaccine (FMP-012) (Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command)
Drug Alias NameFMP012 subunit malaria vaccineFalciparum malaria protein-12 vaccine
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcWalter Reed Army Institute Of ResearchUnited States Army Medical Research And Materiel Command +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAccess to Advanced Health InstituteWalter Reed Army Institute Of ResearchGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A